×
DaVita Common Stock Net 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita common stock net for the quarter ending June 30, 2024 was
$0.000B
, a
1.1% decline
year-over-year.
DaVita common stock net for 2023 was
$0B
, a
1.11% decline
from 2022.
DaVita common stock net for 2022 was
$0B
, a
7.22% decline
from 2021.
DaVita common stock net for 2021 was
$0B
, a
11.82% decline
from 2020.
View More
DaVita Common Stock Net 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita common stock net for 2023 was
$0B
, a
1.11% decline
from 2022.
DaVita common stock net for 2022 was
$0B
, a
7.22% decline
from 2021.
DaVita common stock net for 2021 was
$0B
, a
11.82% decline
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
Encompass Health (EHC)
$9.3B
Chemed (CHE)
$8.7B
Elanco Animal Health (ELAN)
$7.2B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$5B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.8B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$208M
Daxor (DXR)
$45M
ATI Physical Therapy (ATIP)
$25M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
Novo Integrated Sciences (NVOS)
$6M
IMAC Holdings (BACK)
$2M